Extracorporeal Membrane Oxygenation Market
According to Intent Market Research, the Extracorporeal Membrane Oxygenation Market is expected to grow from USD 284.8 million in 2023 at a CAGR of 5.7% to touch USD 421.2 million by 2030. The Extracorporeal Membrane Oxygenation Market is dominated by key players such as Medtronic, LivaNova PLC, Terumo Corporation, Maquet Getinge Group, Fresenius Medical Care, Shimadzu Corporation, Nipro Corporation, Sorin Group, Carmeda AB, Xenios AG, Medos Medizintechnik AG, Eurosets, Getinge AB, M–lnlycke Health Care, Baxter International Inc.